Below are the most recent publications written about "Viral Vaccines" by people in Profiles.
-
Rennert L, Ma Z, McMahan CS, Dean D. Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults. Nat Commun. 2022 07 08; 13(1):3946.
-
Yuen E, Gudis DA, Rowan NR, Nguyen SA, Schlosser RJ. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists. Am J Rhinol Allergy. 2021 Jan; 35(1):122-131.
-
Napier G, Lee D, Robertson C, Lawson A. A Bayesian space-time model for clustering areal units based on their disease trends. Biostatistics. 2019 10 01; 20(4):681-697.
-
Nguyen S, Huleux T, Choisy P, Senneville E, Ajana F. Vaccinal issues between Belgian and French travelers. Med Mal Infect. 2012 Nov; 42(11):545-52.
-
Rehtanz M, Bossart GD, Doescher B, Rector A, Van Ranst M, Fair PA, Jenson AB, Ghim SJ. Bottlenose dolphin (Tursiops truncatus) papillomaviruses: vaccine antigen candidates and screening test development. Vet Microbiol. 2009 Jan 01; 133(1-2):43-53.
-
Frazer IH, Cox JT, Mayeaux EJ, Franco EL, Moscicki AB, Palefsky JM, Ferris DG, Ferenczy AS, Villa LL. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatr Infect Dis J. 2006 Feb; 25(2 Suppl):S65-81, quiz S82.
-
Wang D, Schmaljohn AL, Raja NU, Trubey CM, Juompan LY, Luo M, Deitz SB, Yu H, Woraratanadharm J, Holman DH, Moore KM, Swain BM, Pratt WD, Dong JY. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses. Vaccine. 2006 Apr 05; 24(15):2975-86.
-
Norris JS, Norris KL, Holman DH, El-Zawahry A, Keane TE, Dong JY, Tavassoli M. The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck. Future Oncol. 2005 Feb; 1(1):115-23.
-
Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis. 1998 Jun; 177(6):1664-73.
-
Wang B, Godillot AP, Madaio MP, Weiner DB, Williams WV. Vaccination against pathogenic cells by DNA inoculation. Curr Top Microbiol Immunol. 1998; 226:21-35.